E2F2 Antibody

1. miR-214 overexpression inhibits glioma cell growth in vitro and in vivo by inducing cell cycle arrest in G0/G1. Collectively, these data uncover a novel role for a PPARalpha-miR-214-E2F2 pathway in controlling glioma cell proliferation. PMID: 29862267
2. miR-99a reveals two novel targets E2F2 and EMR2 that play a key role in lung tumourigenesis. By inhibiting E2F2 and EMR2, miR-99a represses in vivo the transition of epithelial cells through an EMT process concomitantly with the inhibition of stemness features and consequently decreasing the CSC population. PMID: 29072692
3. Low E2F2 expression is associated with invasion in clear cell renal cell carcinoma. PMID: 26967247
4. Data indicate E2F transcription factor 2 protein (E2F2) as the direct target of miR-31 in gastric cancer cells. PMID: 27174918
5. These results suggest that miR-125a acts as a tumor suppressor via regulation of E2F2 expression in osteosarcoma progression, and miR-125a may represent a novel therapeutic target for the treatment of osteosarcoma. PMID: 28950256
6. Accordingly, our results demonstrated that NAMPT is a prognostic marker in melanoma, and the identificationofNAMPT-E2F2-SIRT1 pathway establishes another link between NAMPT and apoptosis events in melanoma, with therapeutic implications for this deadly cancer. PMID: 28919418
7. Compared with patients with variant genotypes of E2F2-rs2742976 and E2F2-rs3218123, patients with common homozygous genotypes had better disease-free survival (both log-rank, P < 0.001) and lower squamous cell carcinoma of the oropharynx recurrence risk (HR, 0.4, 95% CI, 0.3-0.6 and HR, 0.3, 95% CI, 0.2-0.5, respectively) after multivariable adjustment. PMID: 27864908
8. Let-7b inhibits the malignant behavior of glioma cells and glioma stem-like cells via downregulation of E2F2. PMID: 27520092
9. In NSCLC patients, E2F2 expression was found to be significantly correlated with sex and tumor size. E2F1 and E2F2 overexpression showed a significant association with poor prognosis. PMID: 27655285
10. Data indicate that microRNA miR-214 has tumor-suppressive activity in hepatocellular carcinoma (HCC) through inhibition of E2F2 transcription factor (E2F2), cyclin-dependent kinases CDK3 and CDK6. PMID: 26498144
11. we validated for the first time that E2F2 acts as a tumor activator in non-small cell lung carcinoma. PMID: 26617764
12. E2F2 loss results in increased lung metastasis in breast cancer, potentially functioning through a PTPRD dependent mechanism. PMID: 26474282
13. Elevated E2F2 expression in glioblastoma cells weakens the effect of elevated levels of miR-218. PMID: 26012781
14. miR218 and miR520a are crucial in the development of hepatocellular carcinoma via the inhibition of cell proliferation and cycle progression by downregulating E2F2. PMID: 25816091
15. miR-31 regulated the proliferation of colon cancer cells by targeting E2F2. PMID: 25362258
16. Results show evidence that let-7a expression in osteosarcoma (OS) cells is significantly reduced and inversely correlated with E2F2 expression levels and that let-7a plays an important role in OS cell proliferation and tumorigenesis by targeting E2F2. PMID: 25647078
17. Overall, miR-155 plays an important role in colorectal carcinoma tumorigenesis by negative regulation of its targets including E2F2. PMID: 24793496
18. Low expression of E2F2 may reflect functional redundancy between members of the E2F family, in this case between E2F1 and E2F2. PMID: 22688350
19. these results indicate that LXR ligands target gene networks, including those regulated by E2F family members, are critical for tumor biology and disease progression and merit further consideration as potential agents PMID: 23809258
20. E2F2 knockdown can inhibit hESC proliferation and tumorigenicity without significantly harming stemness. PMID: 24446828
21. Data suggest that the uniquely increased expression of CD38 and E2F2 in rheumatoid arthritis (RA) synovial tissues contribute to the immunoactivation of the disease. PMID: 24397353
22. ALY is a novel E2F2-interacting protein and a relevant modulator of E2F-responsive gene expression. PMID: 23297349
23. miR-125b plays important roles in regulating the proliferation of cancer stem cells by directly targeting E2F2. PMID: 22999819
24. Overexpression of E2F transcription factor 2 is associated with nonepithelial ovarian cancer. PMID: 22531302
25. Findings suggest that the deregulated activity of E2F in cancer cells causes increased activation of the Kpnbeta1 and Kpnalpha2 promoters, leading to elevated levels of these proteins, and ultimately impacting the cancer phenotype. PMID: 22125623
26. the 3'UTR of E2F2 and CCND2 were directly bound to let-7a and let-7a down-regulated the expression of E2F2 and CCND2, suppressing prostate cancer cell proliferation in culture PMID: 20418948
27. determination of interaction with RYBP and YY1 PMID: 12411495
28. E2F2 has a role in blood pressure regulation via a component of the endothelin system PMID: 12566389
29. Proliferation-promoting E2F transcription factor E2F-2 plays a pivotal role in the tumor biology of ovarian cancer. PMID: 17341621
30. Up-regulation of E2F2 was detected in a set of 54 astrocytomas of different grades and significantly associated with malignancy. PMID: 17588684
31. identify a novel E2F-binding site in the survivin promoter and show that mutation of either the p53- or E2F-binding sites is sufficient to increase promoter activity PMID: 17916908
32. Decreased expression of E2F2 is associated with Increased expression of HER2 in breast tumors. PMID: 19142864
33. miR-24 Inhibits cell proliferation by targeting E2F2, MYC, and other cell-cycle genes via binding to "seedless" 3'UTR microRNA recognition elements. PMID: 19748357

Show More

Hide All

HGNC: 3114

OMIM: 600426

KEGG: hsa:1870

STRING: 9606.ENSP00000355249

UniGene: Hs.194333